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The effects of divalent cations (Zn2+, Cd", Caz+, 
M 8 + )  on the cytosol androgen receptor were deter- 
mined by sedimentation  into  sucrose  gradients. At low 
ionic strength (25 mM KCl, 50 mM Tris, pH 7.4), Zn2+ 
(200 p~ total, which calculates  to 130 nM free Zn2+ in 
10 mM mercaptoethanol)  causes a shift  in  the sedimen- 
tation coefficient of the rat Dunning  prostate  tumor 
(R3327H) cytosol receptor and rat ventral prostate 
cytosol receptor  from 7.5 2 0.3 S to 8.6 2 0.3 S .  Zn2+ 
stabilizes  the 8.6 S receptor  form  in salt concentrations 
up to 0.15 M KC1 in 50 mM Tris, pH 7.2. In low ionic 
strength  gradients containing Ca2+ (2200 p ~ )  or M 8 +  
(rl mM), the receptor  sediments as 4.7 2 0.3 S .  The 
dissociating  effects of Ca" and M e +  can be fully re- 
versed by sedimentation  into  gradients  containing Zn2+ 
(200 pM total) or Cda+ (10 pM total). In the presence of 
Zna+ (200 pM total), Ca" (10 pM to 3 mM) converts  the 
receptor  to an  intermediate  form  with  sedimentation 
coefficient 6.2 2 0.2 S ,  Stokes  radius 73 A, and  appar- 
ent M, - 203,000. The  potentiating  effect of Zna+ on 
formation of the 8.6 S receptor  (in  the absence of  Ca") 
and  the 6.2 S receptor  (in  the preaence of  Ca"') requires 
both the 4.5 S receptor and  the 8 S androgen  receptor- 
promoting  factor. Sodium molybdate stabilizes  the un- 
transformed cytosol receptor  but,  unlike Zn2+, does not 
promote  reconstitution of the 8.6 S receptor  from its 
partially  purified components. These results  indicate 
that divalent  cations alter the molecular size of the 
androgen  receptor in vitro and  thus may have a role 
in  altering  the  state of transformation of the  receptor. 
It has been suggested that transformation of steroid recep- 
tors to a form retained with high affinity in nuclei involves 
disaggregation of a macromolecular complex (1). In vitro 
transformation of receptors has been achieved by exposure to 
increased temperature (2), by raising the  salt concentration 
(3), or by sample dilution (4). The strongest evidence for the 
disaggregation hypothesis comes from studies using the Group 
VIA transition  metal oxyanions, most notably sodium molyb- 
date. Molybdate at a  concentration of 10 mM blocks transfor- 
mation of the avian progesterone receptor (5), the glucocor- 
ticoid receptor (6), androgen (7), and estrogen receptors (8). 
This action of molybdate is thought to result from a  direct 
interaction with the receptor (9) rather  than by inhibition of 
phosphatase activity. Molybdate stabilizes receptors in 8-10 
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S forms that  are relatively insensitive to dissociation in high 
ionic strength buffers (10-13). The untransformed steroid 
receptor is  thus a large M, 2 300,000 complex which, upon 
binding steroid plus unknown events, leads to dissociation to 
a smaller 4-5 S form that binds  tightly  in nuclei. 
Recent studies have indicated that  the 4-5 S form of steroid 
receptors interacts with a nonsteroid binding protein to form 
the 8 S receptor complex. A nonsteroid binding 8 S androgen 
receptor-promoting factor (8 S-PF')  has been identified that 
interacts with the 4.5 S androgen receptor to form the 8 S 
complex (14). Similar observations have been reported for 
estrogen (15) and progesterone (16, 17) receptors. Toft  and 
co-workers (10) have purified the untransformed 8 S proges- 
terone receptor and identified its nonsteroid binding M, 
90,000 subunit. Evidence that supports the physiological im- 
portance of the 8 S form of steroid hormone receptors comes 
from studies showing that  the untransformed glucocorticoid 
receptor of intact cells is 9 S (18). In addition, immunocyto- 
chemical studies have demonstrated the M, 90,000 nonsteroid 
binding component of the untransformed 8 S progesteronc 
receptor in cytoplasm and nuclei of the same cells that contair 
the progesterone-binding B and/or A receptor subunits (19 
20). 
It has been previously reported that  the nonsteroid bindin 
protein component of the androgen receptor, referred to  as 
S-PF, together with Zn2+, influences receptor binding to nuclc 
(21) and  to nuclear matrix (22). Nanomolar levels of free Zn2 
potentiate binding of the 4.5 S receptor to nuclei, while  undc 
the same conditions, 8 S-PF inhibits receptor binding t 
nuclei. In  this report, I  present evidence that Zn2+, Ca", an 
M$+ reversibly alter  the sedimentation of the androgen rc 
ceptor in  a process that requires the presence of 8 S-PF. 
EXPERIMENTAL PROCEDURES 
Materials 
[1,2,4,5,6,7-SH]Dihydrotestosterone (120 Ci/mmol) was purchasec 
from Amersham; cellulose phosphate P-11 from Whatman; diisopro- 
pyl fluorophosphate from Calbiochem-Behring; 2-mercaptoethanol 
from Eastman;  Trizma base (Tris buffer) and ovalbumin from Sigma; 
bovine y-globulin (fraction 11) from Miles Laboratories; acepromazine 
maleate injection (10 mg/ml) from Med Tech Inc.; ketamine hydro- 
chloride (Ketaset) (100 mg/ml) from Bristol Laboratories; and diva- 
lent ion salts, sodium molybdate, ScintiVerse, and reagent grade 
chemicals from Fisher. 
Methods 
Animals-Copenhagen rats (50-100 g; 3 weeks of age) were ob- 
tained from Charles River Breeding Laboratories, Wilmington, MA. 
The abbreviation used  is: 8 S-PF, 8 S androgen receptor-promot- 
ing factor. 
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The donor rat bearing the R3327H Dunning tumor was obtained 
from the Papanicolaou Cancer Research Institute, Miami, FL. An- 
esthetized rats received bilateral subcutaneous transplantations of 
the R3327H Dunning tumor. At each transplantation site, several 
small pieces of tumor were inserted. Tumor tissue was obtained from 
a donor rat  and minced in tissue culture medium. Rats were anesthe- 
tized using a 1:l mixture of acepromazine maleate (10 mg/ml)/ 
ketamine (100 mg/ml) administered  intraperitoneally at a dose of 0.1 
m1/100 g of body weight. When the tumors reached a size of  2-4 cm 
in diameter, rats were castrated through an abdominal or scrotal 
incision. Twenty-four hours  later, rats were killed by decapitation. 
Tumors and ventral  prostate were removed rapidly, rinsed in 0.9% 
NaCl at 0 "C, immersed in liquid nitrogen, and stored at  -70 "C. 
Preparation of Receptor  Fractions-All procedures were carried out 
at 4 "C unless otherwise indicated. Dunning  prostate  tumor  or  ventral 
prostate was pulverized with a  mortar and pestle under liquid nitrogen 
and homogenized using an  Ultraturrax (four intermittent 15-s bursts) 
in buffer containing 10% glycerol, 1 mM 2-mercaptoethanol, 2 mM 
diisopropyl fluorophosphate, 50 mM Tris, pH 7.5. In some experi- 
ments, homogenizing buffer also  contained 1 mM EDTA or 10 mM 
sodium molybdate at  pH 7.0. All pH determinations were at  4 "C. 
The homogenate was centrifuged at  100,000 X g,. in a Beckman 
type 35 rotor for 90 min at 33,000 rpm. Supernatant (cytosol) was 
removed, taking care to avoid the surface lipid. Cytosol was stored in 
small aliquots a t  -70 "C for not longer than 1 month. 
Receptor in cytosol fractions was labeled with 15 nM [3H]dihydro- 
testosterone in the presence of 10 mM 2-mercaptoethanol for 1 h at  
0 "C. This  short incubation time was found to minimize nonspecific 
binding to albumin present  in cytosol (see Fig. 1). Labeled samples 
(0.3 ml) were treated with a 2000 X g pellet of 0.5 ml  of a 1% charcoal 
solution containing 0.1% dextran, 0.1% gelatin (purified from calf 
skin), 10 mM Tris, pH 7.4, as previously described (23). After a 15- 
min incubation on charcoal with intermittent shaking, charcoal was 
removed by centrifugation (2000 X g for 5 min). Various ions were 
added for 15-30 min at  0 "C. In some experiments, small columns of 
Sephadex G-25 in I-ml disposable pipette tips were used to remove 
endogenous ions and other small molecules by brief sedimentation 
for 2 min at  500 X g as previously described for desalting DNA 
solutions  (24).  In  other  experiments, labeled receptor was partially 
purified from cytosol by chromatography on phosphocellulose as 
previously described (14, 22). This procedure results  in  separation of 
the 8 S-PF from the 4.5 S androgen receptor (14). 
The 8 S androgen receptor-promoting factor was isolated from rat 
serum as previously described (14) by precipitation with (NH4)SOt 
at  40% saturation. The pellet was resuspended in 50 mM Tris,  pH 
7.4, and dialyzed overnight  against he same buffer to remove residual 
(NHI)$3O,. The dialysate was chromatographed on  a DEAE-Sepha- 
rose column (2.5 X 30 cm) equilibrated in 50 mM Tris,  pH 7.4. When 
the optical density of the column established a base-line reading after 
washing with 50 mM Tris, pH 7.4, the column was sequentially eluted 
with 0.08 M KC1 and 0.22 M KCl. The fraction  eluting as  the trailing 
shoulder of the protein peak at  0.22 M KC1 contained most of the 8 
S-PF activity and was pooled, dialyzed, and stored frozen at  -70 "C. 
This fraction contained 1-2 mg of protein/ml and was used in 
experiments to  test  the ffect of 8 S-PF on receptor size under various 
ionic conditions. 
Sucrose Gradient Centrifugation-Linear sucrose gradients (2- 
20%, w/v) of 4.8  ml contained 10 mM 2-mercaptoethanol, 10% glyc- 
erol, 0.025 M KCl, and 50 mM Tris, pH 7.4, unless otherwise indicated. 
Cytosol samples labeled with 15 nM [3H]dihydr~testo~ter~ne wer
treated with charcoal as described above. Charcoal-treated samples 
and partially purified receptor fractions from phosphocellulose chro- 
matography (200 or 250 pl) were layered together with protein stand- 
ards ovalbumin (3.6 s) (40 pl of  40 mg/ml) and bovine y-globulin (7 
S) (40 pl of 35 mg/ml). Gradients were centrifuged in an  SW 50.1 
Beckman rotor for 21 h at 4 "C at 46,000 rpm. Gradients were 
fractionated (0.22 ml/fraction) and aliquots (25 pl) were taken for 
protein determination (25). Fractions were combined with 4 ml of 
ScintiVerse/toluene (1:l) and counted in minivials. Counting effi- 
ciency was 34%. 
Analytical Procedures-Protein concentration was estimated by 
the method of Lowry et al. (25) using bovine serum albumin as 
standard.  Free Zn2+ concentration in the presence of mercaptoethanol 
was calculated using a modified Scatchard analysis (21), without 
taking into account possible binding of Zn2+ to proteins in the 
solutions. 
RESULTS 
Effect of Zinc on  Receptor Sedimentation in Cytosol-The 
[3H]dihydrotestosterone-labeled androgen receptor in Dun- 
ning  prostate  tumor R3327H cytosol sediments at 7.5 f 0.3 S 
when assayed in sucrose gradients of  low ionic strength (0.025 
M KCl, 0.05 M Tris,  pH 7.4) (Fig. 1). Nonspecific binding to 
cytosol components such as albumin (4.6 S) was found to be 
minimized when assessed by labeling cytosol for 1 h at 0 "C 
with 15 nM [3H]dihydrotestosterone in  the presence and  ab- 
sence of a 100-fold excess of unlabeled dihydrotestosterone. 
The 7.5-8 S androgen receptor shown in Fig. 1 is common to 
androgen-dependent tissues of the  rat (26). 
I set  out to establish the effect of Zn2+ and  other  divalent 
cations on androgen receptor sedimentation since it was found 
earlier that Zn2+ potentiates receptor binding to nuclear ma- 
trix when assayed in  the absence of the 8 S-PF (21,22). The 
concentration of Zn2+ used in most of the experiments de- 
scribed below is 200 p~ total, which, in  the presence of 10 
mM mercaptoethanol, corresponds to a calculated free Zn2+ 
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FIG. 1. Stabilization of the 9-10 S androgen receptor from 
Dunning prostate tumor by Zn2+ and sodium molybdate. Dun- 
ning tumor cytosol was labeled with 15 nM [3H]dihydrotestosterone 
in the presence of 10 mM mercaptoethanol for 1 h at 0 "C. Sodium 
molybdate was added to  the labeled cytosol sample (0.3 ml) to a  final 
concentration of 10 mM. ZnClz  was added to another 0.3-ml labeled 
cytosol sample to a final total concentration of 200 pM. In  control 
experiments which received no additions, cytosol was labeled as above 
in the presence (A) or absence (A) of a 100-fold excess unlabeled 
steroid. After 30 min at  0 "C, free steroid was  removed by charcoal 
adsorption. The sample that contained sodium molybdate (0) was 
assayed in a sucrose gradient at  pH 7.0 containing 10 mM sodium 
molybdate, 25 mM KCl, 10% glycerol, 10 mM mercaptoethanol, 50 
mM Tris,  pH 7.0. The sample that contained Zn2+ (0) was analyzed 
in  a sucrose gradient at  pH 7.4 containing 200 p M  total  znz+, 10 mM 
mercaptoethanol (equivalent to 130 nm free ZnZ+), 25 mM KCl, 10% 
glycerol, 50 mM Tris, pH 7.4. Sedimentation markers were run as 
internal standards and  are indicated for bovine y-globulin (7 S) and 
ovalbumin (3.6 S). 
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mercaptoethanol(21). At 200 p~ total, Znz+ causes a shift in TABLE I 
the sedimentation coefficient of the androgen receptor from Moleculnr f o r m  of the Dunniw tumor  cytosol  androgen  receptor 
7.5 f 0.3 S to 8.6 f 0.3 s (Fig. 1). An essentially identical Dunning prostate tumor cytosol receptor labeled with 15 nM [3H] 
shift  in receptor sedimentation was also observed using veri- dihydrotestosterone was analyzed at  the indicated KC1 concentrations 
tral  prostate cytosol (not shown). in sucrose gradients containing 10% glycerol, 200 IM ZnClp, 10 mM mercaptoethanol, 50 mM Tris, pH 7.2. 
niscent of sodium molybdate stabilization of steroid receptors [KC11 
in forms of  9-10 S (10-13). As shown in Fig. 1,lO mM sodium M 
molybdate causes the androgen receptor from Dunning  tumor 0.025 7.5 f 0.3 S 8.6 f 0.3 S 
cytosol to sediment  predominantly as 9.8 f 0.2 S at  pH 7.0. 0.05 6.3 f 0.3 S 8.4 f 0.3 S 
In ventral  prostate cytosol, receptor sediments as 10 f 0.2 S 0.10 5.5 f 0.4 S 8.3 & 0.3 S 
in  the presence of 10 mM molybdate (not shown). Concentra- 
0.15 4.7 f 0.3 S 8.0 f 0.4 S" 
effect this shift to 10 s, but 5 mM is sufficient to produce the stabilize the 8-9 s receptor. 
10 S form. 
The Zn2+-induced shift  in receptor sedimentation  is remi- - Zna+ + Zn" 
tions of sodium molybdate for 1 m~ or below are unable to to -1 IrM free Zna+) and a 2-3 volume cytosol were required to 
a In the gradient containing 0.15 M KCI, 500 WM Zn2+ (equivalent 
~~ ~~ 
Dissociation of the 8 S Androgen Receptor Complex by Ca", 
M?+, and KC1 in  the Absence of Added Zn2+-The addition 
of Ca2+ to Dunning  tumor cytosol a t  concentrations ranging 
between 200 p~ and 3 mM Caz+ causes conversion of the 7.5 
S [3H]dihydrotestosterone-labeled receptor to 4.7 f 0.3 S in 
sucrose gradients of low ionic strength (0.025 M KC1, 0.05 M 
Tris,  pH 7.4) (Fig. 2). The lowest concentration of Ca2+ (200 
p ~ )  is effective only after passing the cytosol through  Seph- 
adex G-25 to remove endogenous ions and  other small mole- 
cules. M$+ at  concentrations 2 1  mM has  the same dissociat- 
ing effect as Ca2+ (Fig. 2; see also Fig.  3, right). The addition 
of a lower concentration of caz+ (50 pM) or M%+ (200 pM) to 
cytosol after passage through Sephadex G-25 causes the re- 
ceptor to sediment as 6.3 f 0.3 s. A shift  to about 6.3 S is 
also observed in 50 mM KC1 in  the absence of divalent  cations 
(Table I). At salt concentrations  greater than 50 mM KC1 in 
50 mM Tris, receptor sedimentation  approaches 4.5 S (Table 
I). Thus, receptor sedimentation between 8 S and 4.5 S is 
7 s  36s 











FIG. 2. Interacting effects of Ca", M$+, and Zn'+ on andro- 
gen receptor size. Tumor cytosol samples labeled with 15 nM ['HI 
dihydrotestosterone in  the presence of 10 mM mercaptoethanol were 
incubated for 30 min at 0 "C with 3 mM CaC12 (A), 3 mM CaC12 plus 
200 p~ ZnClz (O), or 3 mM M&12 plus 200 p M  ZnC12 (0). Unbound 
steroid was removed by charcoal treatment. Samples were analyzed 
on sucrose gradients containing the same ion concentrations plus 25 
mM KC1,lO mM mercaptoethanol, 10% glycerol, 50 mM Tris, pH 7.4. 
The addition of 21 mM M$+ to sample and sucrose gradients pro- 
duces a curve identical to that shown for Cap+. 
directly related to  the concentration of Ca", Mp"', or salt. 
Importantly, only a single peak of varying size  was observed 
in these experiments, suggesting that the 4.5 S and 8 S 
receptor forms are interconvertible, where the 8 S form is 
favored at low ionic strength. KC1, Caz+, or MgZ+ shift the 
size of the receptor toward the 4.5 S form probably by favoring 
increased dissociation of the 8 S receptor into  its components. 
The concentration of Ca2+ or MgZ+ required for the shift in 
sedimentation coefficient of the androgen receptor from 8 S 
to 4.5 S is 100-500-fold less than  that required for KCl. 
Interacting Effects of Ca2+, M?+, and KC1 with Zn2+  and 
Sodium Molybdate-When cytosol receptor is analyzed in  the 
presence of  200 pM Zn2+ with 10 mM mercaptoethanol (equiv- 
alent to a calculated free Zn2+ of 130 nM) plus a range in 
concentrations of ca2+ from 10 p M  to 3 mM, the receptor 
sediments at 6.2 f 0.2 S (Fig.  2). A Stokes radius of 73 k 5 A 
was estimated using a cytosol fraction that was concentrated 
by (NH,),SO, precipitation (40% saturated) and chromato- 
graphed on Sepharose 6B equilibrated in 3 mM Ca2+, 200 p~ 
Znz+, 10 mM mercaptoethanol, 10% glycerol, 25 mM KC1, 50 
mM Tris, pH 7.4. A M, of  203,000  was calculated for the 6.2 
S form from hydrodynamic measurements as previously de- 
scribed (26), using as internal  standards fibrinogen (Stokes 
radius 110 A), ferritin (80 A), and y-globulin (52 A). Thus, in 
the presence of Zn2+, calcium does not convert the 8 S, -90- 
A receptor to  its 4.5 S, 58-A (26) form as  it does in  the absence 
of Zn2+, but stabilizes an intermediate form of  6.2 S, 73 A. 
In similar studies, M%+ is even less effective than Ca2+ in 
dissociating the receptor to a slower sedimenting form in  the 
presence of Znz+. In gradients containing 3 mM Mg2+ plus 200 
p~ total Zn2+ and 10 mM mercaptoethanol, the receptor 
sediments  as a doublet of 8 S and 6.2 S (Fig. 2). 
The addition of 3 mM Ca2+ in  the presence of 10 mM sodium 
molybdate at  pH 7.0 also blocks the ability of molybdate to 
stabilize the 10 S receptor, resulting instead  in a 7.3 S receptor 
(not shown). M%+ (3 mM) is significantly less effective than 
Ca2+ in  disrupting the 10 S molybdate-stabilized form of the 
receptor just  as  it  is with Zn2+. 
The ability of zinc to stabilize the 8-9 S receptor in the 
absence of Ca2+ or M%+ was investigated under conditions of 
increasing ionic strength. In  the presence of  50 mM KC1 and 
50 mM Tris, pH 7.4, the 6.3 S receptor detected in the absence 
of Zn2+ is converted to 8.4 S when 200 p~ total Zn2+ is 
included in sample and gradient buffers (Table  I).  In 0.1 M 
KC1 and 50 mM Tris,  pH 7.2, the receptor shifts from 5.5 S 
to 8.3 S upon the addition of Znz+ (200 p~ total,  Table I). 
Stabilization of the 8 S receptor in 0.15 M KC1, 50 mM Tris, 
pH 7.2, requires a concentration of 500 p~ total  2n2+, which 
is calculated to be equivalent to a free ZnZ+ concentration of 
1 p M  in  the presence of 10 mM mercaptoethanol. Thus, Znz+ 
acts to stabilize the 8-9 S androgen receptor so that the 
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complex is less readily dissociated in buffer of increasing ionic 
strength. An important difference in  the dissociating effects 
of  KC1 and Ca2+ in  the presence of Zn2+ was that KC1 did not 
promote formation of the 6.2 S intermediate form. 
The dissociating effects of  KC1 could also be  overcome with 
the use of high concentrations of sodium molybdate. Stabili- 
zation of the 10 S receptor is achieved in 0.15 or 0.4 M KC1 
at  pH 7.0  by a molybdate concentration of 50 mM (data  not 
shown). A concentration of 10 mM sodium molybdate was 
insufficient to stabilize the receptor at these  salt  concentra- 
tions. Molybdate stabilization of large receptor forms has 
been observed for the estrogen (11) and androgen receptors 
(28). 
Experiments were carried out to  test whether the changes 
in receptor sedimentation from 8 S to 4.5 S caused by Ca2+ or 
M e  and from 4.5 S to 8-9 S caused by Zn2+ are reversible. 
Cytosol receptor labeled with [3H]dihydrotestosterone was 
incubated in buffer containing 25 mM KC1 plus either  3 mM 
M e  or 200 p~ total Zn2+, and sedimented into gradients 
containing  3 mM M e ,  or 200 PM total Zn2+, or  3 mM EDTA. 
As shown in Fig.  3,  left, Zn2+-containing samples sediment as 
8 s in  a gradient containing 200 p~ total Zn2+ and  as 5.2 s in 
a  gradient  containing  3 mM M e .  Mp-containing samples 
sediment  as 8 S (with  a  6 S shoulder)  in  gradients with Zn2+ 
and  as  5 S in gradients with Mg2+ (Fig.  3, right). When  Zn2+- 
or Me-containing samples are sedimented into gradients 
containing  3 mM EDTA, the receptor sediments as 6 S and 
6.4 S, respectively. The addition of EDTA to the Ca2+- or 
Mg2+-containing sample prior to application to gradients con- 
taining EDTA effects the complete shift back to 8 s. Essen- 
tially identical results  are observed when Ca2+ is used in these 
experiments  rather than  Mg+.  The 6.2 S receptor observed 
in  the presence of Ca2+ plus Zn2+ sediments as 8 S or 4.7 f 
0.3 S in  gradients  containing Zn2+ or Ca2+, respectively (not 
shown). These data indicate that divalent cations induce 
reversible shifts  in the sedimentation behavior of the receptor. 
A summary of the effects of Zn2+, Ca2+, and M%+ on receptor 
size is presented  in  Table 11. 
pH Dependence of Receptor Sedimentation-The pH de- 
pendence of zinc stabilization of the androgen receptor was 
investigated. In control experiments in the absence of Zn2+, 
the sedimentation coefficient of the androgen receptor de- 
creases with increasing pH when assayed under standard 
IS 3.65 75 365 
FRACTION  NUMBER 
FIG. 3. Reversibility of ZnP+- and M$+-induced changes in 
androgen receptor sedimentation. The [3H]dihydrotestosterone- 
labeled cytosol of Dunning  tumor was made either 200 p~ total ZnClz 
(130 nM free zn") (left) or 3 mM MgClz (right). After a 30-min 
incubation at 0 "C, samples were treated with charcoal to remove 
unbound steroid and sedimented into gradients  containing 200 p~ 
total ZnCl2, or 3 mM EDTA, or 3 mM MgCl,, as indicated. The 
tained  3 mM MgC12 but  the gradient  contained  3 mM EDTA. 
notation, e.g. M$+ + EDTA, implies that  the cytosol sample con- 
TABLE I1
Effects of divalent cations on  the molecular forms of the androgen 
receptor 
Molecular forms of the Dunning  tumor cytosol androgen receptor 
were determined using cytosol fractions and sucrose gradients con- 
taining the indicated divalent cations plus 25 mM KCl, 10% glycerol, 
10 mM mercaptoethanol, and 50 mM Tris, pH 7.4. The free Zn2+ 
concentration of 130 nM (200 p M  total Zn2+ in the presence of 10 mM 
mercaptoethanol) is calculated as previously described (21). In  the 
studies with Ca2+ and M e ,  cytosol samples were pretreated by 
chromatography through Sephadex G-25 to remove endogenous ions. 
Divalent cation Receptor form 
No addition 
3 mM EDTA 
7.5 f 0.3 S 
130 nM free Zn2+ 
7.5 & 0.3 S 
8.6 f 0.3 S 
130 nM free Zn2+ + 21 mM M%+ 8.6 f 0.3 s, 6.2 f 0.2 S 
130 nM free Znz+ + 210 p~ Ca2+ 6.2 f 0.2 S 
2200 PM Ca2+ 
21 mM M$+ 
4.7 f 0.3 S 
4.7 f 0.3 S 
A. ZINC B.SODlUM MOLYBDATE 
 IO 2 0  IO 2 0  
FRACTION NUMBER FRACTION NUMBER 
FIG. 4. The pH dependence of 8-10 S receptor stabilization 
by Zn'+ and sodium molybdate. Tumor cytosol was adjusted to 
pH 7.0 and 7.6 at 0 "C and labeled in the presence of  10 mM 
mercaptoethanol with 15 nM [3H]dihydrotestosterone for 1 h at 0 "C. 
A ,  ZnClz was added to a total concentration of 200 p~ to cytosol 
samples and gradients at  pH 7.0 (0) or 7.6 (0). E ,  sodium molybdate 
was added to 10 mM to samples and sucrose gradients a t  pH 7.0 (0) 
and 7.6 (0). After a 20-min incubation, cytosol samples were treated 
with charcoal to remove excess unbound steroid and analyzed by 
sucrose gradient centrifugation. 
conditions of 25 mM KC1, 50 mM Tris, 10% glycerol, 10 mM 
mercaptoethanol as follows: 7.9 f 0.3 S at  pH 7.0, 7.5 f 0.3 S 
at pH 7.4, 7.0 f 0.2 S at pH 7.6, 6.7 f 0.2 S at  pH 8. The 
influence of Zn2+ on receptor sedimentation was also found 
to be pH-dependent. At a pH of  7.6 or greater, Zn2+  becomes 
ineffective in stabilizing the 8-9 S androgen receptor. In the 
presence of 200 p M  total Zn2+ and 10 mM mercaptoethanol, 
the receptor sediments predominantly as 6.3 S at pH 7.6 
rather  than  as 8.4 S at  pH 7.0 (Fig. 4A). The binding affinity 
between Zn2+ and mercaptoethanol increases by  2-3-fold 
when the  pH is raised from 7.2 to 7.8, resulting in  a lower free 
Zn2+ concentration at pH 7.8. This does not completely ac- 
count, however, for the loss in Zn2+ stabilization, since an 
increase in the Zn2+ concentration up to 1 mM at pH 7.8 
produced no significant change in receptor sedimentation. 
The pH also influences the ability of Zn2+ to counteract the 
dissociating effects of salt.  In 0.1 M KC1 and 50 mM Tris, Zn2+ 
promotes 8.3 f 0.3 S receptor formation at pH 6.8-7.2. 
At pH values 27.4, androgen receptor forms of 6.5-7 S are 
observed. 
The pH dependence of Zn2+ stabilization was compared 
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with that of sodium molybdate. As shown in Fig. 4B, molyb- 
date  stabilization of the 9.8 f 0.2 S receptor is observed at 
pH 7.0. However, 10 mM sodium molybdate is effective only 
to a very limited extent  in stabilizing the 8-10 S androgen 
receptor at  pH 7.6. These  results  demonstrate  a similarity in 
the  pH dependence of 8-10 S androgen receptor stabilization 
by zinc and sodium molybdate; both require pH 6.8-7.2 for 
maximal stabilization. A similar pH (between 6.6 and 7.1) was 
also required for molybdate stabilization of androgen binding 
activity (29). 
Divalent Cation Specificity-Other divalent cations were 
tested for their effects on androgen receptor sedimentation. 
Divalent  cations that have 8 S receptor dissociating effects 
similar to Caz+ and M e  include Mn2+ and Cu". Fez+ (200 
p ~ )  in  the gradient produced a 6.2 S receptor. On  the  other 
hand, Cd2+, and to a lesser extent,  NiZ+ were found to promote 
8 S receptor formation. Cadmium is  in  fact more potent than 
Znz+, since only 10 p M  total Cd" (in 50 mM  KC1, 10 mM 
mercaptoethanol, 50 mM Tris,  pH 7.2) is required to shift the 
6.1 s receptor to 8.4 s. In contrast, 200 pM total zn2+ is 
required for the same conversion. It was noted previously that 
mercaptoethanol  binds Cd2+ more avidly than Zn2+ (21). The 
estimated free CdZ+ concentration is <6 nM as opposed to 130 
nM free Zn2+. It is interesting that  the two ions most effective 
in  promoting 8 S receptor formation, i.e. ZnZ+ and Cd2+, are 
Group IIB  transition metals. 
Divalent Cation Effects on the  Partially Purified 4.5 S Re- 
ceptor and 8 S-PF--It has been observed previously that Zn2+ 
does not alter the sedimentation of the 4.5-5 S androgen 
receptor when it  has been partially purified by phosphocellu- 
lose chromatography (21). This procedure results in separa- 
tion of 8 S-PF from the 4.5 S receptor (15). One possibility 
was, therefore, that Zn2+ potentiates 8 S receptor formation 
by promoting the interaction of the 4.5 S receptor with the 
nonsteroid binding component of the receptor, 8 S-PF. 
Reconstitution  studies were carried  out to test  this hypoth- 
esis using partially purified 4.5 S androgen receptor and 
partially purified 8 S-PF. In  the experiment shown in Fig. 5, 
the  amount of partially purified 8 S-PF used (530 pg  of total 
protein) does not convert the 4.5 S receptor to 8 S in  the 
absence of added Zn2+. Addition of 200 p~ total Zn2+ in  the 
presence of 10 mM mercaptoethanol to  this sample and to  the 
sucrose gradient  converts the receptor from the 4.5 S to  the 8 
S sedimentation form (Fig. 5). Thus, Zn2+ promotes 8 S 
receptor reconstitution from partially purified 4.5 S receptor 
and 8 S-PF protein fractions. In a parallel experiment, the 
addition of 10 mM sodium molybdate at pH 7.0 did not 
promote 8 S receptor reconstitution (Fig. 5). These results 
suggest that the 4.5 S receptor or 8 S-PF may undergo 
modification during isolation, which abolishes the stabiiizing 
effect of molybdate, but  not  that observed with ZnZ+. 
Reconstitution of the 8 S receptor from the partially  puri- 
fied 4.5 S receptor and 8 S-PF occurs in  the absence of added 
Zn2+ at high concentrations of 8 S-PF (15). Stabilization of 
the reconstituted 8 S complex is also achieved in the absence 
of added Zn2+ by lowering the  salt concentration from 25 to 
15 mM KC1 (not shown). When the receptor is reconstituted 
in buffer containing Zn2+ and Ca2+ (Fig. 6), the intermediate 
6.2 S receptor is observed just  as it is in cytosol (see Fig. 2). 
These  observations suggest that  the interaction of the  par- 
tially purified 4.5 S androgen receptor with 8 S-PF generates 
the same molecular forms of the receptor observed in cytosol. 
The loss of the stabilizing influence of molybdate suggests the 
possibility of an irreversible change in receptor or 8 S-PF  that 
is  not  detected by divalent  cations. 
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FIG. 5. Influence of Zna+ and sodium molybdate on recon- 
stitution of the 8 S receptor from the 4.5 S receptor and 8 S- 
PF. The 4.5 S [3H]dihydrotestosterone-labeled androgen receptor 
was partially purified by phosphocellulose chromatography (PC) as 
previously described (14).  The 8 S-PF was isolated from  rat  serum as 
described  under "Experimental Procedures." The receptor  peak elut- 
ing from phosphocellulose at 0.3 M KC1 was dialyzed alone (0) or 
combined with 530 pg of a protein fraction containing 8 S-PF and 
dialyzed for 2 h against 10% glycerol, 10 mM mercaptoethanol, 0.025 
M KCl, 50 mM Tris, pH 7.0. To the fractions containing 8 S-PF, there 
were no further additions (O), sodium molybdate  was  added to 10 mM 
(B), or ZnClz was added to 200 p~ total (A). After 30 min at 0 "C, 
samples were applied to sucrose gradients at pH 7.0 containing the 
same concentration of  molybdate or Zn2+ as the sample. 
The size of the androgen receptor following precipitation with 
40% saturated  (NH4)2S04 varies depending on the tissue and 
the assay conditions. With EDTA (1 mM) in cytosol prior to 
precipitation with (NH4)2S04,  an 8 S receptor is observed as 
shown previously (26). The receptor forms recovered from 
cytosol containing EDTA reflect a sensitivity to zinc, calcium, 
and magnesium similar to that observed with the cytosol 
receptor (not shown). In  the absence of EDTA prior to pre- 
cipitation with (NH4),SO4, the receptor is rarely recovered in 
an 8 S form when assayed under standard conditions of 25 
mM  KC1, 50 mM Tris, pH 7.4. In ventral prostate in the 
absence of EDTA, receptor is not detectable following 
(NH4),S04 precipitation, probably due to the high level of 
proteases in this tissue (26). The Dunning tumor receptor 
sedimentation following (NH4),S04 pecipitation in the ab- 
sence of EDTA varies from 5.5-7 S, with an average sedimen- 
tation of 6.4 S (not shown). In contrast to  the ventral  prostate, 
there was  no evidence of receptor proteolysis during prepa- 
rations from the Dunning  tumor since receptor forms below 
4.5 S were not observed. The addition of Znz+ to  this receptor 
fraction was usually ineffective in altering  its sedimentation. 
Re-formation to  the 8 S following (NH4)&304 fractionation  in 
the absence of EDTA requires the addition of 8 S-PF or crude 
cytosol. 
These  results suggest the possibility that during  fractiona- 
tion with (NH4)2SO4 in  the absence of EDTA, the association 
between 8 S-PF  and  the 4.5 S receptor is weakened, perhaps 
due to separation of 8 S-PF from the 4.5 S receptor. This 
could be caused hv the dissociating effect of salt together with 
endogenous Ca" and M$+ in cytosol in the absence of EDTA. 
A loss of 8 S-PF during  (NH4),S04  fractionation may  be one 
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FIG. 6. Stabilization of the 6.2 S reconstituted androgen 
receptor by Ca2+ and Zna+. The phosphocellulose-purified, [3H] 
dihydrotestosterone-labeled 4.5 S receptor  was combined with 520 pg 
of protein fraction containing 8 S-PF partially purified as described 
under “Experimental Procedures.” Samples were dialyzed for 2 h at 
4 “c against 10% glycerol, 10 mM mercaptoethanol, 25 mM KCI, and 
50 mM Tris, pH 7.4. The samples and gradients had no further 
addition (01, contained 3 mM CaC& plus 200 PM total  ZnC& (0), or 
200 p~ total ZnC1, (A). 
explanation for the observation that salting-out  in (NH,),SO, 
promotes transformation of steroid receptors (30). 
DISCUSSION 
This  report  demonstrates that interconversion of androgen 
receptor forms between 8.6 S, 6.2 S and 4.5 S is a reversible 
process influenced by divalent  cations, ionic strength,  and  the 
nonsteroid binding component of the receptor, referred to as 
8 S-PF.  This interaction  can be summarized by the equation 
below. 
Zn’+, CdZ+ 
4.5 S + 8 S-PF q;::, MT 2f6 
Zn2+ + CaZ+ Zn2+ + Ca2+ 
6.2 S 
In  the absence of divalent  cations and  at low ionic strength, 
the 8 S form of the androgen receptor predominates. Ca2+, 
M F ,  and KC1 promote dissociation of the 8 S receptor to 4.5 
S at ion concentrations  near the physiological range. Their 
dissociating effect is counteracted by Zn2+ and Cd2+, which at 
calculated nanomolar free ion concentrations promote 8-9 S 
receptor formation by stabilizing the interaction between the 
4.5 S steroid binding component  and the nonsteroid binding 
component 8 S-PF.  In  the presence of both Zn2+ and Ca2+, 
there  appears to occur a change in the interaction of the 4.5 
S receptor with 8 S-PF so that  an intermediate 6.2 S receptor 
is observed. 
The 6.2 S intermediate form may simply reflect an equilib- 
rium between 8 S and 4.5 S forms during centrifugation in 
the absence of  Zn2+.  However, in  the presence of Zn2+ plus 
Ca2+-  or M$+-containing buffer, it appears  as  a more stable 
intermediate. One possibility is that  the 6.2 S receptor is a 
complex of the 4.5 S receptor with a  subunit of 8 S-PF. Based 
on a M, of 117,000 for the 4.5 S, 58-A receptor (26), an 
additional component of M, - 86,000 appears to be associated 
in the 6.2 S receptor (estimated M, 203,000). Although the 
subunit composition of androgen receptor 8 S-PF remains to 
be established, Toft and co-workers (17)) using reducing and 
denaturing gels, and  Joab et al. (19) have described a  non- 
steroid binding protein component of the progesterone recep- 
tor of M, 90,000. It is conceivable that  the M, - 170,000 8 S- 
PF consists of two subunits of similar size, one of which 
remains associated in  the 6.2 S intermediate. It is likely not 
a dimer or multimer of the steroid binding unit since under 
no condition was the sedimentation  rate of the 4.5 S receptor 
increased in the absence of 8 S-PF.  This is in contrast to  the 
6 S progesterone receptor which is reported to be a dimer of 
the steroid binding components of the progesterone receptor 
(31,32). 
All  of the experiments in this  study were carried out  in the 
presence of mercaptoethanol, since zinc in the absence of 
mercaptoethanol causes the receptor to aggregate and sedi- 
ment to  the bottom of the gradient tube (21). It is therefore 
not clear at present whether zinc in  its free form or  as  a zinc- 
mercaptoethanol complex reacts with the receptor. Zinc or its 
complex probably binds directly to  the 4.5 S androgen receptor 
in an ionic or easily dissociable form rather  than via 8 S-PF. 
Support for this hypothesis is that 1) the 4.5 S receptor but 
not 8 S-PF is retained by a Znz+-specific chelating agarose 
column,2 2) Zn2+ potentiates binding of the 4.5 S receptor to 
nuclear matrix (21,  22), and 3) Zn2+ inhibits binding of [3H] 
dihydrotestosterone to  the 4.5 S receptor when added before 
the androgen (21, 34). The inhibition is reversed by the 
addition of EDTA? Zn2+ might act  as  a bridging atom between 
the 4.5 S receptor and 8 S-PF in a manner similar to  the 
general mechanism linking enzymes and  substrates (35). Zn2+ 
might also bridge the 4.5 S receptor to a component of the 
nuclear matrix (22). 
Znz+ is  present at relatively high levels in  the male repro- 
ductive tract (36), has been  closely correlated with androgen 
action (37)) and is thought to be required for normal growth 
and development of the male sex organs (38, 39). Together 
with previous studies on Zn2+ potentiation of receptor binding 
to nuclear matrix (21,  22), it is tempting to speculate that a 
crucial role of Zn2+ in the male reproductive tract is at  the 
level  of the androgen receptor. Cadmium was the only divalent 
cation as  potent  as zinc in promoting 8-9 S androgen receptor 
formation. This is curious since cadmium has been closely 
linked with alterations in zinc uptake (39) and has been 
implicated in  prostate carcinoma. Industrial workers exposed 
to cadmium are reported to suffer from a high incidence of 
prostate cancer (40). The  testis  is also highly susceptible to 
damage by cadmium (41). An interesting hypothesis might be 
that  the unusual stabilizing influence of Cd” on the 8-9 S 
androgen receptor (at least 20 times more  effective than Zn2+) 
is related to  its toxic effects in the prostate  and  testis. 
There is some precedent for the dissociating effects of 
divalent cations such as M$+ and Ca2+ on steroid receptors. 
A recent  report by Fukai and Murayama (42) indicates that 
10 mM M F  disrupts the reconstituted 8 S estrogen receptor, 
but  not the “native” receptor found in porcine uterine cytosol. 
I did not  detect  a difference between native  and  reconstituted 
androgen receptors with regard to divalent cation-induced 
dissociation. In another report, 5 mM Ca2+ was found to 
dissociate the 8 S estrogen receptor (43). However, in neither 
of these  studies was there  an  attempt  to demonstrate revers- 
’ D. S. Colvard and E. M. Wilson, unpublished observations. 
E. M. Wilson, unpublished observations. 
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ibility of divalent  cation-induced dissociation. This is impor- 
tant in light of the known sensitivity of the estrogen (44) and 
progesterone receptors (45) to Ca2+-induced proteolytic cleav- 
age to smaller receptor forms that retain the high affinity 
steroid binding site. We know, for example, that  the 4.5 S 
androgen receptor is susceptible to proteolytic cleavage to 3.6 
S and 3.0 S forms that bind [3H]dihydr~te~to~ter~ne with 
high affinity (26), and  that  this proteolytic cleavage is  en- 
hanced by divalent  cations?  Furthermore, the 3.0 S androgen 
receptor fragment  has  apparently  lost  a recognition site for 8 
S-PF so that  it can no longer be reconstituted to  the 8 S 
complex (46). 
It has been shown previously that the 4.5 S androgen 
receptor separated from 8 S-PF by phosphocellulose chro- 
matography binds to nuclear matrix with high affinity (1013 
M-') when assayed in the presence of 0.15 M KC1,3 mM M$+, 
300 p~ Zn2+, and 5 mM mercaptoethanol (equivalent to - 0.47 PM free Zn") (21,22). Zinc and mercaptoethanol were 
essential  components in the binding reaction. Furthermore, 
binding of the 4.5 S receptor was inhibited by the addition of 
fractions containing partially purified 8 S-PF. In some re- 
spects, these observations are difficult to reconcile with the 
data presented here that Zn2+ potentiates  formation of the 8- 
9 S receptor. In agreement with a previous report  (33), one 
explanation may be that  an irreversible change has occurred 
in the receptor or 8 S-PF during  their  partial purification that 
was reflected in the inability of sodium molybdate to recon- 
stitute  the 8 S receptor from its partially purified components. 
It may be that this undefined change has increased the 
stability of the 8 S complex to allow for inhibition of binding 
of the partially purified receptor to matrix by 8 S-PF. Another 
possibility in explaining the apparent discrepancy is that, 
while M$+ is  not very effective in dissociating the 8 S recep- 
tor, Caz+ at low concentrations (10 pM) in the presence of 
Zn2+ promotes partial dissociation of the 8-9 S receptor to 6.2 
S, perhaps  thereby changing the interaction of the receptor 
with nuclear matrix. The binding affinity of 6.2 S androgen 
receptor for nuclear matrix  sites  remains to be established. 
Acknowledgments-The dedicated technical assistance of Bryan T. 
Wright is greatly appreciated. Dr. Frank S. French provided encour- 
agement and a critical review of the manuscript. Lacy  E. Thornburg 
performed the tumor  transplantations. 
REFERENCES 
1. Atger, M., and Milgrom, E. (1976) J.  Biol.  Chem. 251,4758-4762 
2. Schmidt, T. J., and Litwack, G. (1982) Physiol. Rev. 6 2 ,  1131- 
3. Milgrom, E., Atger, M., and Baulieu, E. E. (1973) Biochemistry 
4. Higgins, S. J., Rousseau, G. G., Baxter, J. D., and Tomkins, G. 
M. (1973) J.  Biol. Chem. 248,5866-5872 
5. Toft, D., and Nishigori, H. (1979) J.  Steroid Biochem. 11, 413- 
416 
6. Leach, K. L., Dahmer, M. K., Hammond, N.  D., Sando, J. J., and 
Pratt, W.  B. (1979) J.  Biol.  Chem. 254, 11884-11890 
7. Noma, K., Nakao, K., Sato, B., Nishizawa, Y., Matsumoto, K., 
and Yamamura, Y. (1980) Endocrinology 107 ,  1205-1211 
8. Shyamala, G., and Leonard, L. (1980) J.  Biol.  Chem. 255,6028- 
6031 
9. Housley, P. R., Grippo, J. F., Dahmer, M. K., and  Pratt, W. B. 
(1984) in Biochemical Actions of Hormones (Litwack, G., ed) 
Vol. XI, pp. 347-376, Academic Press, New York 
10. Puri, R. K., Grandics, P., Dougherty, J. J., and Toft, D. 0. (1982) 
J. Biol.  Chem. 257. 10831-10837 
11. Miller, L. K., Tuazon, F. B., Niu, E. M., and Sherman, M. R, 
(1981) Endocrinology 108, 1369-1378 
1192 
12,5198-5205 
12. Grody, W. W., Compton, J. G., Schrader, W. T.,  and O'Malley, 
13. McBlain, W. A., Toft, D. O., and Shyamala, G. (1981) Biochem- 
14. Colvard, D. S., and Wilson, E. M. (1981) Endocrinology 109 ,  
15. Murayama, A., Fukai, F., and Yamamoto, T. (1980) J.  Biochem. 
16. Murayama, A., Fukai, F., and Yamamoto, T. (1980) J.  Biochem. 
17. Dougherty, J. J., Puri, R. K., and Toft, D. 0. (1984) J.  Biol. 
Chem. 259,8004-8009 
18. Holbrook, N. J., Bodwell, J. E., Jeffries, M., and Munck, A. (1983) 
J. Biol.  Chem. 258,6477-6485 
19. Joab, I., Radanyi, C., Renoir, M., Buchou, T., Catelli, M.-G., 
Binart, N., Mester, J., and Bauleiu, E.-E. (1984) Nature 308 ,  
20. Gasc, J. M., Renoir, J. M., Radanyi, C., Joab, I., Tuohimaa, P., 
21. Colvard, D. S., and Wilson, E. M. (1984) Biochemistry 23,3471- 
22. Colvard, D. S., and Wilson, E. M. (1984) Biochemistry 23,3479- 
23. Wilson, E. M., and French, F. S. (1976) J.  Biol. Chem. 251 ,  
24. Maniatis, T., Fritsch, E.  F., and Sambrook, J. (1982) Molecular 
Cloning: A  Laboratory  Manual, pp. 466-467 Cold Spring  Harbor 
Laboratory, Cold Spring Harbor, NY 
25. Lowry, 0. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. 
(1951) J.  Biol. Chem. 193 ,  265-275 
26. Wilson, E. M., and French, F. S. (1979) J. Biol. Chem. 254 ,  
27. Deleted in proof 
28. Rowley, D. R., Chang, C. H., and Tindall, D. J. (1984) Endocri- 
29. Wright, W. W., Chan, K.  C., and Bardin, C.  W. (1981) Endocri- 
30. Buller, R. E., Toft, D. O., Schrader, W. T., and O'Malley, B.  W. 
(1975) J.  Biol.  Chem. 250,801-808 
31. Kuhn, R. W., Schrader, W. T., Smith, R. G., and O'Malley, B. 
W. (1975) J. Biol.  Chem. 250,4220-4228 
32. Grody, W. W., Schrader, W. T., and O'Malley, B. W. (1982) 
Endocr.  Rev. 3, 141-163 
33. Dahmer, M. K., Housley, P. R., and  Pratt, W. B. (1984) Annu. 
Rev.  Physiol. 46,67-81 
34 Donovan, M. P., Schein, L. G., and Thomas, J. A. (1980) Mol. 
Pharmacol. 17, 156-162 
35. Saltman, P., Hegenauer, J., and Strause, L. (1984) in Metabolism 
of Trace  Met&  in  Man:  Developmental  Aspects. (Rennert, 0. 
M., and Chan, W. Y., eds) pp. 1-16, CRC Press, Inc., Boca 
Raton, FL 
36. Mann, T. (1964) The Biochemistry of Semen and of the Male 
Reproductive  Tract, Methuen & Co., Ltd., London 
37. Habib, F.  K. (1978) J. Steroid Biochern. 9,403-407 
38. Sandstead, H. H., Prasad, A. S., Schulert, A.  R., Farid, Z., Miale, 
A., Bassilly, S., and Darby, W. J. (1967) Am. J.  Clin. Nutr. 2 0 ,  
39. Reed, M. J., and Stitch, S. R. (1973) J.  Endocrinol. 58,405-419 
40. Kipling, M. D., and Waterhouse, J. A. H. (1967) Lancet I, 730- 
731 
41. Gunn, S. A., and Gould, T. C. (1970) in The  Testis (Johnson, A. 
D., Gomes,  W.  R., and Vandemark, N. L., eds) Vol. 3, pp. 377- 
481, Academic Press, New York 




(Tokyo) 88, 1305-1315 
850-853 








42. Fukai, F., and Murayama, A. (1984) J.  Biochem. (Tokyo) 9 5 ,  
1227-1230 
43. Ratajczak, T., Luc, T., Samec, A. M., and Hahnel, R. (1981) 
44. Puca, G.  A., Nola, E., Sica, V., and Bresciani, F. (1972) Biochem- 
45. Tuohimaa, P., Mester, J., Renoir, J. M., Catelli, M. G., Binart, 
N., Buchou, T., and Baulieu, E. E. (1984) J. Steroid  Biochem. 
FEBS  Lett. 136,115-118 
istry 11,4157-4165 
20,429-432 
46. Wilson, E. M., and Colvard, D. S. (1984) Ann. N. Y.  Acad. Sci. 
438,85-100 
